NCT06015269

Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Shanghai Cell Therapy Group Co.,Ltd · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This is an exploratory study on the safety, immune response, and preliminary effectiveness of single arm, fixed dose therapy

Detailed description

This study is a clinical study exploring the safety, immune response, and preliminary efficacy of a single arm, 1x107cells dose.

Conditions

• Solid Tumor

Interventions

Type	Name	Description
DRUG	DC cells	At a single arm, 1x107cells dose

Timeline

• Start date: 2023-08-01
• Primary completion: 2025-07-01
• Completion: 2025-07-01
• First posted: 2023-08-29
• Last updated: 2023-08-29

Locations

1 site across 1 country: China